Publication | Open Access
Erenumab in chronic migraine
109
Citations
19
References
2019
Year
This study provides Class II evidence that for patients with CM, erenumab treatment improves HRQoL, headache impact, and disability.
| Year | Citations | |
|---|---|---|
Page 1
Page 1